These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10215131)

  • 1. Gynaecomastia associated with saquinavir therapy.
    Donovan B; Bodsworth NJ; Mulhall BP; Allen D
    Int J STD AIDS; 1999 Jan; 10(1):49-50. PubMed ID: 10215131
    [No Abstract]   [Full Text] [Related]  

  • 2. Gynaecomastia associated with combination antiretroviral therapy including protease inhibitors for human immunodeficiency virus infection.
    Post JJ
    Int J STD AIDS; 1999 Apr; 10(4):275-6. PubMed ID: 12035783
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute paranoid reaction to saquinavir.
    Finlayson JA; Laing RB
    Am J Health Syst Pharm; 1998 Oct; 55(19):2016-7. PubMed ID: 9784791
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety profile of soft gelatin formulation of saquinavir in combination with nucleosides in a broad patient population. NV15182 Study Team.
    Gill MJ
    AIDS; 1998 Jul; 12(11):1400-2. PubMed ID: 9708428
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid lowering therapy in patients with HIV infection.
    McBride M; Chin MT; Lee SM; Kelly B
    Lancet; 1998 Nov; 352(9142):1782-3. PubMed ID: 9848377
    [No Abstract]   [Full Text] [Related]  

  • 7. Ritonavir and saquinavir combination therapy for the treatment of HIV infection.
    Cameron DW; Japour AJ; Xu Y; Hsu A; Mellors J; Farthing C; Cohen C; Poretz D; Markowitz M; Follansbee S; Angel JB; McMahon D; Ho D; Devanarayan V; Rode R; Salgo M; Kempf DJ; Granneman R; Leonard JM; Sun E
    AIDS; 1999 Feb; 13(2):213-24. PubMed ID: 10202827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal calculi developing de novo in a patient taking saquinavir.
    Green ST; McKendrick MW; Schmid ML; Mohsen AH; Prakasam SF
    Int J STD AIDS; 1998 Sep; 9(9):555. PubMed ID: 9764943
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-HIV agents. Starting therapy with saquinavir.
    TreatmentUpdate; 2007 Jan; 19(1):8-9. PubMed ID: 17393566
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient.
    Weir A; Wansbrough-Jones M
    AIDS; 1997 Dec; 11(15):1895-6. PubMed ID: 9412716
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute hepatitis in a patient treated with saquinavir and ritonavir: absence of cross-toxicity with indinavir.
    Vandercam B; Moreau M; Horsmans C; Gala JL
    Infection; 1998; 26(5):313. PubMed ID: 9795794
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evidence-based therapeutic drug monitoring for saquinavir].
    Muret P; Solas C;
    Therapie; 2011; 66(3):207-12. PubMed ID: 21819804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.
    Kirk O; Katzenstein TL; Gerstoft J; Mathiesen L; Nielsen H; Pedersen C; Lundgren JD
    AIDS; 1999 Jan; 13(1):F9-16. PubMed ID: 10207539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eruptive angiolipomas associated with antiretroviral therapy.
    Daudén E; Alvarez S; García-Díez A
    AIDS; 2002 Mar; 16(5):805-6. PubMed ID: 11964545
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased methadone effect after ritonavir initiation.
    Geletko SM; Erickson AD
    Pharmacotherapy; 2000 Jan; 20(1):93-4. PubMed ID: 10641980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
    Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P
    Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV agents. Promising results from a saquinavir study.
    TreatmentUpdate; 2007 Jan; 19(1):9-10. PubMed ID: 17390482
    [No Abstract]   [Full Text] [Related]  

  • 18. [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():44. PubMed ID: 15373047
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
    Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C
    Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV agents. Atazanavir and saquinavir.
    TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.